Article ID Journal Published Year Pages File Type
9253740 Journal of Hepatology 2005 6 Pages PDF
Abstract
HBeAg status, HBV-DNA, ALT levels and treatment duration are the major determinants for the YMDD mutation during lamivudine therapy, and should be considered in designing the therapeutic strategy.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Gastroenterology
Preview
Virus and transaminase levels determine the emergence of drug resistance during long-term lamivudine therapy in chronic hepatitis B
Authors
, , , ,